Introduction to real-world evidence studies
- PMID: 34386383
- PMCID: PMC8323556
- DOI: 10.4103/picr.picr_62_21
Introduction to real-world evidence studies
Conflict of interest statement
Dr Deepa Chodankar is an employee of Sanofi India and might be shareholders of Sanofi.
References
-
- Framework for FDA's Real-World Evidence Program. US: Food and Drugs Administration; 2018.
-
- Monti S, Grosso V, Todoerti M, Caporali R. Randomized controlled trials and real-world data: Differences and similarities to untangle literature data. Rheumatology. 2018;57:vii54–8. - PubMed
-
- National Academies of Sciences. Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Drug Discovery, Development, and Translation. Real. World Evidence Generation and Evaluation of Therapeutics: Proceedings of a Workshop. 3, Opportunities for Real-World Data. Washington (DC): National Academies Press (US); 2017. Feb 15, [Last accessed on 2021 Jan 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441694/ - PubMed
LinkOut - more resources
Full Text Sources